"We want to be part of that fight to keep people well" - Dr. Grammer on WUSA 9

Greenbrook's Chief Medical Officer, Dr. Geoffrey Grammer, was recently on WUSA 9 discussing Greenbrook TMS therapy. Beyond explaining the basic mechnisms of using TMS therapy for treatment-resistant depression and obsessive compulsive disorder (OCD), Dr.

Greenbrook's Chief Medical Officer, Dr. Geoffrey Grammer , was recently on WUSA 9 discussing Greenbrook TMS therapy. Beyond explaining the fundamental mechanisms of using TMS therapy for treatment-resistant depression and Obsessive-Compulsive Disorder (OCD), Dr. Grammer also explained what makes TMS a more tailored treatment to each individual's brain. Unlike antidepressants, which can have systemic side effects such as nausea or weight gain and which don't provide adequate relief from depression symptoms for about one-third of the people taking them, TMS therapy  uses gentle magnetic pulses to re-activate the parts of the brain responsible for depression.

During the segment, Dr. Grammer also discussed the specific ways in which we're responding to the COVID-19 crisis to keep patients and staff safe while still providing this important treatment for those struggling with treatment-resistant depression. Dr. Grammer says that "The CDC [Centers for Disease Control and Prevention] is encouraging people who are engaged in mental health care to stay engaged in mental health care, and we definitely want to be part of that fight to help keep people well and, candidly, to keep people home and healthy as opposed to having to go to the hospital or the emergency room, which right now is the front line of the pandemic." Because TMS therapy is a treatment with daily center visits, we've instituted a variety of hygiene and social distancing measures, explained by Dr. Grammer in the segment. 

Watch below to see the segment in full:

To see all upcoming Greenbrook TMS provider interviews, click here